| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.24B | 1.15B | 1.10B | 1.03B | 957.04M | 1.20B |
| Gross Profit | 531.45M | 450.75M | 443.09M | 413.74M | 372.73M | 496.66M |
| EBITDA | 77.50M | 37.50M | 358.55M | -19.67M | -63.67M | 82.08M |
| Net Income | 102.62M | 42.81M | 228.96M | -44.04M | -111.83M | 46.18M |
Balance Sheet | ||||||
| Total Assets | 1.51B | 1.55B | 1.48B | 1.32B | 1.35B | 1.33B |
| Cash, Cash Equivalents and Short-Term Investments | 1.14B | 1.11B | 1.20B | 769.49M | 811.06M | 980.10M |
| Total Debt | 1.75M | 2.27M | 4.32M | 6.29M | 0.00 | 0.00 |
| Total Liabilities | 309.74M | 366.19M | 337.30M | 260.45M | 243.77M | 243.75M |
| Stockholders Equity | 1.20B | 1.19B | 1.15B | 1.06B | 1.11B | 1.09B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -26.99M | -41.29M | -48.04M | -156.42M | 863.00K |
| Operating Cash Flow | 0.00 | -20.06M | -25.93M | -41.21M | -151.49M | 47.43M |
| Investing Cash Flow | 0.00 | -66.37M | 459.15M | 3.72M | 1.52M | -51.54M |
| Financing Cash Flow | 0.00 | -2.05M | -1.97M | -4.08M | -19.08M | 296.87M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥18.09B | 26.25 | ― | 0.17% | 31.39% | 13.12% | |
62 Neutral | ¥2.78B | 19.11 | ― | 0.58% | 25.37% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥45.24B | 34.36 | ― | 0.90% | 25.06% | 37.24% | |
51 Neutral | ¥2.37B | -9.68 | ― | ― | 20.46% | 37.56% | |
45 Neutral | ¥1.42B | -6.74 | ― | ― | -3.49% | -2246.63% |
SecuAvail Inc. has received approval from the Tokyo Stock Exchange to transfer its listing from the Growth Market to the Standard Market, with the change taking effect on January 21, 2026 and the share transfer scheduled for January 28, 2026. The company, which fully meets all listing maintenance criteria for the Standard Market, has withdrawn its previous plan to comply with Growth Market requirements and says the move will support its long-term, subscription-based network security business while reinforcing its commitment to capital-efficiency-focused management, medium-term growth targets, and the broader social responsibilities expected of a provider of infrastructure-grade security services.
The most recent analyst rating on (JP:3042) stock is a Hold with a Yen409.00 price target. To see the full list of analyst forecasts on SecuAvail, Inc. stock, see the JP:3042 Stock Forecast page.
SecuAvail, Inc. reported a significant financial turnaround for the six months ending September 30, 2025, with a notable increase in net sales and profitability compared to the previous year. The company’s financial results indicate a strong recovery and improved market positioning, with expectations of continued growth in the fiscal year ending March 31, 2026, as reflected in their financial forecasts.
The most recent analyst rating on (JP:3042) stock is a Hold with a Yen369.00 price target. To see the full list of analyst forecasts on SecuAvail, Inc. stock, see the JP:3042 Stock Forecast page.